• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Pathol Lab Med . Comparison of Mid-turbinate Nasal Swabs, Saliva and Nasopharyngeal Swabs for SARSCoV-2 Reverse Transcription Polymerase Chain

tetano

Editor, Senior Moderator
Arch Pathol Lab Med


. 2022 May 16.
doi: 10.5858/arpa.2021-0625-SA. Online ahead of print.
Comparison of Mid-turbinate Nasal Swabs, Saliva and Nasopharyngeal Swabs for SARSCoV-2 Reverse Transcription Polymerase Chain Reaction Testing in Pediatric Outpatients


Miriam B Vos[SUP] 1 [/SUP], Mark D Gonzalez[SUP] 2 [/SUP], Cheryl Stone[SUP] 3 [/SUP], Rebecca Cleeton[SUP] 1 [/SUP], Janet Figueroa[SUP] 4 [/SUP], Robert Jerris[SUP] 2 [/SUP], Sunita I Park[SUP] 2 [/SUP], Stacy Heilman[SUP] 1 [/SUP], Risha Nayee[SUP] 1 4 [/SUP], Ann Chahroudi[SUP] 1 [/SUP], Nils Schoof[SUP] 4 [/SUP], Maud Mavigner[SUP] 4 [/SUP], Claudia R Morris[SUP] 1 [/SUP], Traci Leong[SUP] 5 [/SUP], Amanda Grindle[SUP] 6 [/SUP], Adrianna Westbrook[SUP] 4 [/SUP], Wilbur Lam[SUP] 1 7 [/SUP], Beverly B Rogers[SUP] 2 [/SUP]



Affiliations

Abstract

Context.–: Diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in symptomatic and asymptomatic children remains integral to care, particularly for supporting return to and attendance in schools. The concordance of SARS-CoV-2 detection in children using various specimen types has not been widely studied.
Objective.–: To compare three sample types for SARS-CoV-2 PCR testing in children collected and tested at a single facility.
Design.–: We prospectively recruited 142 symptomatic and asymptomatic children into a sample comparison study performed in a single healthcare system. Each child provided self-collected saliva, and a trained healthcare provider collected a mid-turbinate nasal swab and nasopharyngeal (NP) swab. Specimens were assayed within 24 hours of collection using reverse transcriptase-polymerase chain reaction (RT-PCR) to detect SARS-CoV-2 on a single testing platform.
Results.–: Concurrently collected saliva and mid-turbinate swabs had >95% positive agreement with NP swabs when obtained within 10 days of symptom onset. Positive agreement of saliva and mid-turbinate samples collected from children with symptom onset >10 days prior, or without symptoms, was 82% compared to NP swab samples. Cycle threshold (Ct) values for mid-turbinate nasal samples more closely correlated with Ct values from NP samples than saliva sample Ct values.
Conclusions.–: These findings suggest that all three sample types from children are useful for SARS-CoV-2 diagnostic testing by RT-PCR, and that concordance is greatest when the child has symptoms of coronavirus disease 2019 (COVID-19) within the past 10 days. This study provides scientific justification for utilizing sample types other than the NP swab for SARS-CoV-2 testing in pediatric populations.
 
Back
Top Bottom